Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Crossref DOI link: https://doi.org/10.1007/s40273-016-0481-1
Published Online: 2016-12-10
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uttley, Lesley https://orcid.org/0000-0003-4603-9069
Whyte, Sophie
Gomersall, Timothy
Ren, Shijie
Wong, Ruth
Chambers, Duncan
Tappenden, Paul
Funding for this research was provided by:
Health Technology Assessment Programme (12/64/01)
License valid from 2016-12-10